Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions consistently emphasize the innovative use of MDMA and LSD in Swiss clinical settings, citing researchers like Peter Gasser and Peter Oehen, and noting the potential for these substances to transform trauma treatment. The tone is generally positive, reflecting fascination and support, with some reminders of the historical and legal context that adds depth to the conversation.
Most discussions support the article, highlighting its innovative approach and potential benefits of psychedelics in therapy.
The discussions demonstrate strong curiosity and enthusiasm for the Swiss model, with many highlighting the novelty and potential of MDMA and LSD in clinical practice.
Participants engage by referencing key researchers, sharing related studies, and expressing opinions about legalization and effectiveness.
The conversations suggest the article could influence perceptions and discussions around psychedelic therapy, but mostly within academic and clinical circles.
New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, which was active from 2015 through 2020. https://t.co/vlO9KPS6fb
MDMA followed by LSD in the therapeutic context. Combination treatments are used underground, could they emerge as effective? https://t.co/CjobzoYSKH @REMAPTherapy @ee_schenberg #psychedelics
This interesting study explores a group #therapy model for combined #MDMA and #LSD therapy geared towards #trauma conditions. Using these #psychedelic substances in tandem was effective, with most participants showing clinical improvement. https://t.co/l1bmz3VBEJ
Here is MK ULTRA https://t.co/D1boqbdAtu
psychedelic therapy has been legal in Switzerland between 1988 - 1993 and from 2014 - ongoing ("compassionate use" of LSD, Psilocybin and MDMA). Tap into the experience of Swiss psychiatrists! https://t.co/HCf3DqX1mz
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders https://t.co/bY9MPwEiE6
Discover the evolution of MDMA psychedelic-assisted group therapy for PTSD with Dr. Chris Stauffer. Explore how it influences group dynamics and therapy outcomes, highlighting its potential to expand access to these…
This video explores Switzerland's innovative use of MDMA and LSD in group therapy to treat trauma-related disorders like PTSD and CPTSD, highlighting the developmental process since 2014 and the therapy's effectiveness…
@cptsd2525 治験レベルですが各種サイケデリクスはPTSD周りで研究されてます 純粋な薬物療法というよりセラピーの補助ですが 慶應大学病院も少し研究してます https://t.co/aQzCQC6zWP
@dannytheforde @JulesEvans11 https://t.co/RRYNtZDn6h and https://t.co/WO1VJnozhF and https://t.co/OihdHZ4Xy1
@JulesEvans11 @fredemag Yes, it’s totally misleading to call Australia the first. https://t.co/F6sd0pIUgU
@RebeccaMadison_ Would highly recommend Not to be “that guy”, but psychedelics seem to be the one substance that magically solves most mental health items (I quit smoking because of it) https://t.co/wZNlLWxq8E
@noxheav3n https://t.co/PJftZ5muTu
psychedelic therapy has been legal in Switzerland between 1988 - 1993 and from 2014 - ongoing ("compassionate use" of LSD, Psilocybin and MDMA). Tap into the experience of Swiss psychiatrists! https://t.co/HCf3DqX1mz
RT @ViewsOnDrugsBot: Using a #MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Traum…
https://t.co/wiOWyOCwjv
Here is MK ULTRA https://t.co/D1boqbdAtu
From the related https://t.co/ccCJhVvkZP article: “Stillness is considered a tool of confrontation” Powerful language, signaling one of the risks of the under-trained, overly-interrupting therapist!
@AndrewLittleMP Legalise MDMA and LSD psychotherapy https://t.co/vHS0SEyXzE
So many gems in here. Peter Gasser & Peter Oehen on MDMA + LSD for c-PTSD. https://t.co/540jjsbyDb
Using a #MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders 1/5 https://t.co/YaXEbM31qb
RT @Psychedelic_Med: This interesting study explores a group #therapy model for combined #MDMA and #LSD therapy geared towards #trauma cond…
https://t.co/wiOWyOCwjv
This interesting study explores a group #therapy model for combined #MDMA and #LSD therapy geared towards #trauma conditions. Using these #psychedelic substances in tandem was effective, with most participants showing clinical improvement. https://t.co/l1bmz3VBEJ
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders https://t.co/8VMor1MXRo https://t.co/dke2yxkqrm
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders https://t.co/bY9MPwEiE6
@MichaelHaichin https://t.co/TBekxNeSPm
https://t.co/ENELamDowU
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
RT @mattbagg: New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, wh…
New open access publication in which Peter Oehen and Peter Gasser describe their group psychedelic psychotherapy practice, which was active from 2015 through 2020. https://t.co/vlO9KPS6fb
RT @jamesbclose: MDMA followed by LSD in the therapeutic context. Combination treatments are used underground, could they emerge as effecti…
I had no idea that the Swiss had developed this pathway to psychedelic therapy. Very interesting strategy and protocol elaborated here. https://t.co/SUB98nwmFf
RT @jamesbclose: MDMA followed by LSD in the therapeutic context. Combination treatments are used underground, could they emerge as effecti…
RT @jamesbclose: MDMA followed by LSD in the therapeutic context. Combination treatments are used underground, could they emerge as effecti…
MDMA followed by LSD in the therapeutic context. Combination treatments are used underground, could they emerge as effective? https://t.co/CjobzoYSKH @REMAPTherapy @ee_schenberg #psychedelics
http://dx.doi.org/10.3389/fpsyt.2013.00118 Army. J. Affect. Disord., 2014 ... 2022.863552 an outpatient veteran sample. J. Psychiatr. Res., 2022, 156 ...
Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders. Front Psychiatry, 13, 863552. https://doi.org/10.3389/fpsyt.2022.863552
https://www.frontiersin.org/articles/10.3389/fpsyt.2022.863552/full; Smith KW, et al. (2022). MDMA-assisted psychotherapy for treatment of ...
... 10.3389/fpsyt.2022.863552 Schechter MD. 'Candyflipping': synergistic discriminative effect of LSD and MDMA. Eur J Pharmacol. 1998 Jan 12;341 ...
MB
JC
PA
M
L
AA
ち
NL
KG
LR
A
VD
GL
TN
VP
SB
EG
K
T
KD
FS
BW
NO
S
MA
L
CE
JF
BB
DB
JM
VP
DK
AL
RT